Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2000 Jan 18;82(2):361–367. doi: 10.1054/bjoc.1999.0927

Expression of a prostate-associated protein, human glandular kallikrein (hK2), in breast tumours and in normal breast secretions

M H Black 1, A Magklara 1, C Obiezu 1, M A Levesque 1, D J A Sutherland 2, D J Tindall 3, C Y F Young 3, E R Sauter 4, E P Diamandis 1
PMCID: PMC2363279  PMID: 10646889

Abstract

The recent demonstration of human glandular kallikrein (hK2) expression in a breast carcinoma cell line has suggested that this putatively prostate-restricted, steroid hormone-regulated protease may also be expressed in breast epithelium in vivo and secreted into the mammary duct system. Given that the only substrate yet identified for hK2 activity is the precursor of prostate-specific antigen (PSA), the expression of which in breast carcinomas may be associated with favourable prognosis, our purpose was to examine the expression pattern of both hK2 and PSA in breast tumour tissues. Cytosolic extracts of 336 primary breast carcinomas prepared for routine oestrogen receptor (ER) and progesterone receptor (PR) analysis, as well as 31 nipple aspirates from six women with non-diseased mammary glands, were assayed for hK2 and PSA using immunofluorometric assays developed by the authors. In the tumour extracts, measurable hK2 and PSA concentrations were detected in 53% and 73% of cases respectively, and were positively correlated to each other (r = 0.59, P = 0.0001). Higher concentrations of PSA and hK2 were found in tumours expressing steroid hormone receptors (P = 0.0001 for PSA and P = 0.0001 for hK2, by Wilcoxon tests for both ER and PR), and both PSA (r = 0.25, P = 0.0001) and hK2 (r = 0.22, P = 0.0001) correlated directly with PR levels. A negative correlation between patient age and PSA (r = –0.12, P = 0.03) was also found. Both proteins were present in nipple aspirate fluid at relatively high concentrations which were positively correlated (r = 0.53, P = 0.002). The molecular weights of the immunoreactive species quantified by the hK2 and PSA assays were established by high-performance liquid chromatography (HPLC) and were consistent with the known molecular weights of hK2 and PSA. Together these data provide the first evidence, to our knowledge, that both malignant breast tissue and normal breast secretion contain measurable quantities of hK2, and that the degree of hK2 expression or secretion is directly proportional to the expression of PSA and steroid hormone receptors. hK2 expression may therefore be a marker of steroid hormone action in breast tissue. © 2000 Cancer Research Campaign

Keywords: breast cancer, prostate cancer, human glandular kallikrein, prostate-specific antigen, kallikrein gene family

Full Text

The Full Text of this article is available as a PDF (89.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Black M. H., Magklara A., Obiezu C. V., Melegos D. N., Diamandis E. P. Development of an ultrasensitive immunoassay for human glandular kallikrein with no cross-reactivity from prostate-specific antigen. Clin Chem. 1999 Jun;45(6 Pt 1):790–799. [PubMed] [Google Scholar]
  2. Clements J. A., Mukhtar A., Verity K., Pullar M., McNeill P., Cummins J., Fuller P. J. Kallikrein gene expression in human pituitary tissues. Clin Endocrinol (Oxf) 1996 Feb;44(2):223–231. doi: 10.1046/j.1365-2265.1996.661481.x. [DOI] [PubMed] [Google Scholar]
  3. Cohen P., Graves H. C., Peehl D. M., Kamarei M., Giudice L. C., Rosenfeld R. G. Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma. J Clin Endocrinol Metab. 1992 Oct;75(4):1046–1053. doi: 10.1210/jcem.75.4.1383255. [DOI] [PubMed] [Google Scholar]
  4. Corey E., Buhler K. R., Vessella R. L. Cross-reactivity of ten anti-prostate-specific antigen monoclonal antibodies with human glandular kallikrein. Urology. 1997 Oct;50(4):567–572. doi: 10.1016/S0090-4295(97)00415-9. [DOI] [PubMed] [Google Scholar]
  5. Cramer S. D., Chen Z., Peehl D. M. Prostate specific antigen cleaves parathyroid hormone-related protein in the PTH-like domain: inactivation of PTHrP-stimulated cAMP accumulation in mouse osteoblasts. J Urol. 1996 Aug;156(2 Pt 1):526–531. doi: 10.1097/00005392-199608000-00076. [DOI] [PubMed] [Google Scholar]
  6. Diamandis E. P. . . . and secreted tumour suppressors. Nat Genet. 1996 Jul;13(3):268–272. doi: 10.1038/ng0796-268a. [DOI] [PubMed] [Google Scholar]
  7. Diamandis E. P., Yu H. New biological functions of prostate-specific antigen? J Clin Endocrinol Metab. 1995 May;80(5):1515–1517. doi: 10.1210/jcem.80.5.7538144. [DOI] [PubMed] [Google Scholar]
  8. Diamandis E. P., Yu H. Nonprostatic sources of prostate-specific antigen. Urol Clin North Am. 1997 May;24(2):275–282. doi: 10.1016/s0094-0143(05)70373-6. [DOI] [PubMed] [Google Scholar]
  9. Diamandis E. P., Yu H., Sutherland D. J. Detection of prostate-specific antigen immunoreactivity in breast tumors. Breast Cancer Res Treat. 1994;32(3):301–310. doi: 10.1007/BF00666007. [DOI] [PubMed] [Google Scholar]
  10. Ferguson R. A., Yu H., Kalyvas M., Zammit S., Diamandis E. P. Ultrasensitive detection of prostate-specific antigen by a time-resolved immunofluorometric assay and the Immulite immunochemiluminescent third-generation assay: potential applications in prostate and breast cancers. Clin Chem. 1996 May;42(5):675–684. [PubMed] [Google Scholar]
  11. Fichtner J., Graves H. C., Thatcher K., Yemoto C., Shortliffe L. M. Prostate specific antigen releases a kinin-like substance on proteolysis of seminal vesicle fluid that stimulates smooth muscle contraction. J Urol. 1996 Feb;155(2):738–742. [PubMed] [Google Scholar]
  12. Finlay J. A., Evans C. L., Day J. R., Payne J. K., Mikolajczyk S. D., Millar L. S., Kuus-Reichel K., Wolfert R. L., Rittenhouse H. G. Development of monoclonal antibodies specific for human glandular kallikrein (hK2): development of a dual antibody immunoassay for hK2 with negligible prostate-specific antigen cross-reactivity. Urology. 1998 May;51(5):804–809. doi: 10.1016/s0090-4295(98)00107-1. [DOI] [PubMed] [Google Scholar]
  13. Foretova L., Garber J. E., Sadowsky N. L., Verselis S. J., Li F. P. Prostate-specific antigen in nipple aspirate. Lancet. 1996 Jun 8;347(9015):1631–1631. doi: 10.1016/s0140-6736(96)91120-4. [DOI] [PubMed] [Google Scholar]
  14. Hsieh M. L., Charlesworth M. C., Goodmanson M., Zhang S., Seay T., Klee G. G., Tindall D. J., Young C. Y. Expression of human prostate-specific glandular kallikrein protein (hK2) in the breast cancer cell line T47-D. Cancer Res. 1997 Jul 1;57(13):2651–2656. [PubMed] [Google Scholar]
  15. Killian C. S., Corral D. A., Kawinski E., Constantine R. I. Mitogenic response of osteoblast cells to prostate-specific antigen suggests an activation of latent TGF-beta and a proteolytic modulation of cell adhesion receptors. Biochem Biophys Res Commun. 1993 Apr 30;192(2):940–947. doi: 10.1006/bbrc.1993.1506. [DOI] [PubMed] [Google Scholar]
  16. Kumar A., Mikolajczyk S. D., Goel A. S., Millar L. S., Saedi M. S. Expression of pro form of prostate-specific antigen by mammalian cells and its conversion to mature, active form by human kallikrein 2. Cancer Res. 1997 Aug 1;57(15):3111–3114. [PubMed] [Google Scholar]
  17. Lai L. C., Erbas H., Lennard T. W., Peaston R. T. Prostate-specific antigen in breast cyst fluid: possible role of prostate-specific antigen in hormone-dependent breast cancer. Int J Cancer. 1996 Jun 11;66(6):743–746. doi: 10.1002/(SICI)1097-0215(19960611)66:6<743::AID-IJC6>3.0.CO;2-#. [DOI] [PubMed] [Google Scholar]
  18. López-Otín C., Diamandis E. P. Breast and prostate cancer: an analysis of common epidemiological, genetic, and biochemical features. Endocr Rev. 1998 Aug;19(4):365–396. doi: 10.1210/edrv.19.4.0337. [DOI] [PubMed] [Google Scholar]
  19. Lövgren J., Piironen T., Overmo C., Dowell B., Karp M., Pettersson K., Lilja H., Lundwall A. Production of recombinant PSA and HK2 and analysis of their immunologic cross-reactivity. Biochem Biophys Res Commun. 1995 Aug 24;213(3):888–895. doi: 10.1006/bbrc.1995.2212. [DOI] [PubMed] [Google Scholar]
  20. Lövgren J., Rajakoski K., Karp M., Lundwall â, Lilja H. Activation of the zymogen form of prostate-specific antigen by human glandular kallikrein 2. Biochem Biophys Res Commun. 1997 Sep 18;238(2):549–555. doi: 10.1006/bbrc.1997.7333. [DOI] [PubMed] [Google Scholar]
  21. McCormack R. T., Rittenhouse H. G., Finlay J. A., Sokoloff R. L., Wang T. J., Wolfert R. L., Lilja H., Oesterling J. E. Molecular forms of prostate-specific antigen and the human kallikrein gene family: a new era. Urology. 1995 May;45(5):729–744. doi: 10.1016/s0090-4295(99)80076-4. [DOI] [PubMed] [Google Scholar]
  22. McGuire W. L., Horwitz K. B., Pearson O. H., Segaloff A. Current status of estrogen and progesterone receptors in breast cancer. Cancer. 1977 Jun;39(6 Suppl):2934–2947. doi: 10.1002/1097-0142(197706)39:6<2934::aid-cncr2820390680>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  23. Piironen T., Lövgren J., Karp M., Eerola R., Lundwall A., Dowell B., Lövgren T., Lilja H., Pettersson K. Immunofluorometric assay for sensitive and specific measurement of human prostatic glandular kallikrein (hK2) in serum. Clin Chem. 1996 Jul;42(7):1034–1041. [PubMed] [Google Scholar]
  24. Riegman P. H., Vlietstra R. J., Suurmeijer L., Cleutjens C. B., Trapman J. Characterization of the human kallikrein locus. Genomics. 1992 Sep;14(1):6–11. doi: 10.1016/s0888-7543(05)80275-7. [DOI] [PubMed] [Google Scholar]
  25. Saedi M. S., Cass M. M., Goel A. S., Grauer L., Hogen K. L., Okaneya T., Griffin B. Y., Klee G. G., Young C. Y., Tindall D. J. Overexpression of a human prostate-specific glandular kallikrein, hK2, in E. coli and generation of antibodies. Mol Cell Endocrinol. 1995 Apr 1;109(2):237–241. doi: 10.1016/0303-7207(95)03508-5. [DOI] [PubMed] [Google Scholar]
  26. Sauter E. R., Daly M., Linahan K., Ehya H., Engstrom P. F., Bonney G., Ross E. A., Yu H., Diamandis E. Prostate-specific antigen levels in nipple aspirate fluid correlate with breast cancer risk. Cancer Epidemiol Biomarkers Prev. 1996 Dec;5(12):967–970. [PubMed] [Google Scholar]
  27. Takayama T. K., Fujikawa K., Davie E. W. Characterization of the precursor of prostate-specific antigen. Activation by trypsin and by human glandular kallikrein. J Biol Chem. 1997 Aug 22;272(34):21582–21588. doi: 10.1074/jbc.272.34.21582. [DOI] [PubMed] [Google Scholar]
  28. Yu H., Diamandis E. P., Levesque M., Giai M., Roagna R., Ponzone R., Sismondi P., Monne M., Croce C. M. Prostate specific antigen in breast cancer, benign breast disease and normal breast tissue. Breast Cancer Res Treat. 1996;40(2):171–178. doi: 10.1007/BF01806212. [DOI] [PubMed] [Google Scholar]
  29. Yu H., Diamandis E. P., Monne M., Croce C. M. Oral contraceptive-induced expression of prostate-specific antigen in the female breast. J Biol Chem. 1995 Mar 24;270(12):6615–6618. doi: 10.1074/jbc.270.12.6615. [DOI] [PubMed] [Google Scholar]
  30. Yu H., Diamandis E. P., Sutherland D. J. Immunoreactive prostate-specific antigen levels in female and male breast tumors and its association with steroid hormone receptors and patient age. Clin Biochem. 1994 Apr;27(2):75–79. doi: 10.1016/0009-9120(94)90015-9. [DOI] [PubMed] [Google Scholar]
  31. Yu H., Giai M., Diamandis E. P., Katsaros D., Sutherland D. J., Levesque M. A., Roagna R., Ponzone R., Sismondi P. Prostate-specific antigen is a new favorable prognostic indicator for women with breast cancer. Cancer Res. 1995 May 15;55(10):2104–2110. [PubMed] [Google Scholar]
  32. Yu H., Levesque M. A., Clark G. M., Diamandis E. P. Prognostic value of prostate-specific antigen for women with breast cancer: a large United States cohort study. Clin Cancer Res. 1998 Jun;4(6):1489–1497. [PubMed] [Google Scholar]
  33. Zarghami N., Grass L., Diamandis E. P. Steroid hormone regulation of prostate-specific antigen gene expression in breast cancer. Br J Cancer. 1997;75(4):579–588. doi: 10.1038/bjc.1997.101. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES